Hydrochloric Acid → HCID 178522488, compound

HRID 1844986Notes

Reaction equation

HRID 1844986 reaction equation
C(OC([N:8]1[CH2:13][CH2:12][C:11]2[N:14]=[C:15]([NH:17][C:18]([C:20]3[C:28]4[NH:27][C:26]([NH:29][C:30]([C:32]5[N:33]=[CH:34][C:35]6[C:40]([CH:41]=5)=[CH:39][CH:38]=[CH:37][CH:36]=6)=[O:31])=[N:25][C:24]=4[CH:23]=[CH:22][CH:21]=3)=[O:19])[S:16][C:10]=2[CH2:9]1)=O)(C)(C)C.Cl>CO>[N:14]1[C:11]2[CH2:12][CH2:13][NH:8][CH2:9][C:10]=2[S:16][C:15]=1[NH:17][C:18]([C:20]1[C:28]2[NH:27][C:26]([NH:29][C:30]([C:32]3[N:33]=[CH:34][C:35]4[C:40]([CH:41]=3)=[CH:39][CH:38]=[CH:37][CH:36]=4)=[O:31])=[N:25][C:24]=2[CH:23]=[CH:22][CH:21]=1)=[O:19]

Participants

4

Procedure

To a solution of 0.2 g (0.35 mmol) of 2-({2-[(isoquinoline-3-carbonyl)-amino]-3H-benzoimidazole-4-carbonyl}-amino)-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-5-carboxylic acid tert-butyl ester in methanol (1 mL) was added HCl solution (5 mL, 4M HCl in 1,4-dioxane). The mixture was stirred at room temperature for 30 min. The conversion was checked by LCMS. After removal of the organic phase, the residue was diluted with DCM (50 mL) and the organic phase was washed with sat. aq. Na2CO3 solution, water, brine, dried over Na2SO4 and concentrated to afford 160 mg (100%) of isoquinoline-3-carboxylic acid [7-(4,5,6,7-tetrahydro-thiazolo[5,4-c]pyridin-2-ylcarbamoyl)-1H-benzoimidazol-2-yl]-amide. LCMS: 470 (M+1)+.

Workup

  1. customAfter removal of the organic phase
  2. additionthe residue was diluted with DCM (50 mL)
  3. washthe organic phase was washed with sat. aq. Na2CO3 solution, water, brine
  4. dry with materialdried over Na2SO4
  5. concentrationconcentrated

Sources & evidence

ORD record
ord-87fac3f05a1644c29253d0c456d81f83
Source dataset
uspto-grants-2015_02
Patent number
US08946259B2

Reaction notes

Loading…